Claudine Bruck
CIK: 0001733680
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (100.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ANVS
Annovis Bio, Inc.
Director
Discretionary Trading P&L
Holdings
About Bruck Claudine
Bruck Claudine (SEC CIK 0001733680) files insider reports with the SEC as Director of Annovis Bio, Inc. (ANVS).
Signal8 holds 1 ownership filing by Bruck Claudine, a Form 4, filed on Nov 12, 2025. Those filings report 1 transaction, the latest on Sep 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Bruck Claudine's filings is in MALVERN, PA.
Recent filings by Bruck Claudine
- Sep 10, 2025: Option exercise of ANVS shares (Form 4, code M).
Other insiders filing for Annovis Bio, Inc. (ANVS)
- Hoffman Michael B, Director
- Maccecchini Maria-Luisa, President & CEO
- Walsh Andrew, Vice President, Finance
- McCarthy Reid, Director